| HS Code | 244792 |
| Product Name | Qingdai Powder Veterinary Grade API |
| Category | Veterinary Active Pharmaceutical Ingredient |
| Botanical Source | Baphicacanthus cusia (Nees) Bremek., Polygonum tinctorium Ait., Isatis indigotica Fort., or Strobilanthes cusia (Nees) Kuntze |
| Active Marker Compounds | Indigo and indirubin |
| Appearance | Fine dark blue powder |
| Odor | Characteristic slight odor |
| Solubility | Practically insoluble in water; slightly soluble in ethanol; soluble in chloroform and dimethyl sulfoxide |
| Storage Conditions | Store in sealed container in a cool, dry place protected from light |
| Shelf Life | 36 months when stored properly |
| Intended Use | Veterinary API for formulation of tablets, injections, capsules, powders, granules, premixes, and solutions |
As an accredited Qingdai Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged in moisture-proof sealed double polyethylene bags with aluminum foil outer pouch, 1 kg net per bag, labeled for veterinary use. |
| Container Loading (20′ FCL) | 20′ FCL loading of Qingdai Powder veterinary API involves palletized, sealed drums/cartons, safely stowed in dry containers with moisture protection. |
| Shipping | Shipped in sealed, moisture-resistant containers to preserve stability. Protect from heat, light, and humidity during transit. Qingdai Powder is a veterinary-grade API requiring compliant labeling and documentation. Worldwide courier available with temperature-controlled options and safe handling protocols. Ensure customs clearance and regulatory paperwork are confirmed before dispatch. |
| Storage | Store Qingdai Powder Veterinary Grade API in a cool, dry, well-ventilated area below 25°C. Keep the container tightly sealed, protected from light, moisture, and strong oxidizing agents. Avoid high humidity and temperature fluctuations. Use clean, dry utensils when handling to prevent contamination. Keep separate from feed, food, and non-medical products in clearly labeled packaging. |
| Shelf Life | Shelf life: 24 months when stored in a cool, dry place, protected from light and moisture, in original sealed container. |
On a production-scale rotary tablet press, Qingdai powder is rarely processed as a direct-compression feed because the platy particle morphology of indigo-bearing material reduces flow through the paddle feeder and increases weight variability at press speeds above 30 rpm. A more reproducible route is wet granulation using 2.5% w/w polyvinylpyrrolidone K30 as binder, with croscarmellose sodium 4.0% w/w as disintegrant and microcrystalline cellulose plus anhydrous dibasic calcium phosphate as the diluent system. The granulation endpoint is reached when the wet mass passes a 1.0 mm screen and yields dried granules with loss on drying of 2.0% to 3.5%. Compression force is typically held between 8 kN and 15 kN for 10.0 mm round flat-faced punch tooling, producing tablet hardness of 60 N to 90 N and friability not more than 1.0% when tested according to USP <1216>. Disintegration time is controlled by the superdisintegrant level and is ordinarily less than 15 min in 37°C water per USP <701>, although tablet hardness above 100 N can extend disintegration beyond 20 min if granule porosity collapses. Content uniformity requires an acceptance value not more than 15 per USP <905>, which is difficult to achieve when the API comprises more than 30% w/w of the final tablet mass because segregation occurs in the feed hopper. The low bulk density of Qingdai powder, commonly below 0.40 g/mL in the ungranulated state, also creates a dusting tendency during transfer; containment is therefore required to protect operators and prevent cross-contamination in a shared facility. Lubrication with magnesium stearate 0.5% w/w for 3 min in a bin blender is preferred; over-lubrication above 5 min can reduce tablet tensile strength below 1.0 MPa when measured diametrically. Dissolution testing per USP <711> is generally conducted in 0.1 N hydrochloric acid or acetate buffer pH 4.5 with paddle speed 50 rpm, but published data for this specific botanical API in veterinary tablet formulations is limited and the dissolution specification must be justified by batch data rather than compendial default.
For injectable dosage forms, the API is not typically presented as a simple aqueous solution because the principal indigo constituents exhibit poor water solubility across pH 4.0 to pH 8.0. A sterile suspension is therefore the more technically defensible presentation when the formulation is intended for intramuscular or subcutaneous administration in cattle or pigs. The suspended phase requires micronization or air-jet milling to a particle size distribution with D90 not more than 20 µm and D50 below 8 µm to reduce needle clogging and local irritation; however, excessive particle size reduction increases total particle surface area and may raise dissolution of water-soluble impurities from the botanical matrix into the aqueous vehicle. The vehicle phase is generally composed of Water for Injection, 0.5% w/w to 1.0% w/w sodium carboxymethylcellulose as suspending agent, 0.1% w/w polysorbate 80 as wetting agent, and sodium chloride as tonicity adjuster. The vehicle is filtered through a 0.22 µm sterilizing-grade membrane, but the API suspension cannot be passed through this filter because the suspended particles would be retained; sterile API prepared by validated dry heat or gamma irradiation must be aseptically incorporated after vehicle sterilization. Terminal steam sterilization at 121°C for 15 min is often unsuitable because indigo and indirubin may degrade or aggregate under saturated steam, and the suspending agent can lose viscosity. Endotoxin control must comply with USP <85>; because botanical raw materials frequently carry high bioburden and endotoxin load, the API must be pre-treated to reduce endotoxin below the calculated limit for the maximum injected volume. The apparent viscosity of the finished suspension should be maintained between 50 mPa·s and 150 mPa·s at 20°C using a Brookfield viscometer spindle 2 at 60 rpm, and syringeability through a 21-gauge needle should be confirmed at 5°C because cold storage increases vehicle viscosity. Particulate matter in the finished suspension is measured by light obscuration per USP <788>, with limits dependent on container volume as shown in the table below. Visible particulate inspection per USP <790> must reject any filled unit with visible foreign particles, while resuspendability is evaluated by manual shaking and must re-disperse sediment within 30 seconds to ensure dose accuracy at the farm. Chemical stability of the suspension can be affected by free water, so the vehicle pH is usually adjusted to pH 5.0 to 6.5 with hydrochloric acid or sodium hydroxide; outside this range the suspending agent may hydrolyze and the suspension may become too viscous or too fluid after autoclaving. Because published data for Qingdai powder specifically formulated as an injectable veterinary suspension is limited, formulation screening should include a forced degradation study at 40°C/75% RH and at pH extremes, coupled with subvisible particle counts and resuspendability measurements rather than relying solely on visual inspection.
| Quality attribute | Test method | Acceptance criterion |
|---|---|---|
| Sterility | USP <71> | No microbial growth |
| Bacterial endotoxins | USP <85> | Not more than calculated limit for product |
| Subvisible particulates, ≤100 mL | USP <788> light obscuration | ≥10 µm: not more than 6000 per container; ≥25 µm: not more than 600 per container |
| Subvisible particulates, >100 mL | USP <788> light obscuration | ≥10 µm: not more than 25 per mL; ≥25 µm: not more than 3 per mL |
| Visible particulates | USP <790> | Essentially free |
In companion-animal capsule filling, the low bulk density of milled Qingdai powder forces the formulator to choose between a granulated intermediate and a densified slugging step rather than direct powder fill. Direct fill is rarely viable because API flow through a dosator nozzle is inconsistent and the tamping pins compress variable plugs at machine speeds above 25,000 capsules/h. A standard capsule formulation for companion animal use may contain 2.0% w/w to 5.0% w/w colloidal silicon dioxide as glidant, 0.5% w/w to 1.0% w/w magnesium stearate, and sufficient lactose monohydrate or mannitol to achieve a fill weight appropriate for size 0 or size 1 capsules. The powder blend is compacted into slugs and milled through a 1.0 mm screen, or granulated in a high-shear mixer with 10% w/w to 15% w/w purified water, then dried at 50°C to 60°C to moisture content below 4.0%. Capsule weight variation must meet USP <905> acceptance value not more than 15, and dissolution testing per USP <711> is used to detect over-lubrication or poor granule disintegration. The hard gelatin shell is sensitive to water activity; if the fill moisture exceeds 60% RH equivalent, the shell may soften or become brittle during storage. Because Qingdai powder contains deeply colored indigo compounds, capsule filling lines require frequent cleaning of contact parts; the color transfer onto dosator pins and tamping pins is not a stability issue but can generate visible product defects in subsequent batches if cleaning protocols are not validated. Automated capsule checkweighers with rejection limits of ±3% around target fill weight are recommended on production lines, because the colored powder makes visual inspection of fill level less reliable than with white or light-colored excipients.
The answer lies in the adhesive and electrostatic interaction between micronized Qingdai particles and the carrier surface. In a feed premix, the API is diluted to a working inclusion rate of 0.1% w/w to 2.0% w/w before the final feed mill mixes it into complete feed at 1 kg to 10 kg per tonne. The carrier is not inert: wheat middlings, rice hulls, ground corn cob and calcium carbonate differ in bulk density, moisture sorption and surface roughness, which directly affect particle adhesion, dusting and segregation. Coarse carriers with high surface area, such as ground corn cob at 300 µm to 800 µm, normally retain fine API particles better than smooth dense carriers such as calcium carbonate, but they may also absorb moisture and promote microbial growth if the water activity exceeds 0.60. Mixing is performed in a horizontal ribbon mixer or paddle mixer with a working capacity of 500 L to 2000 L, and the coefficient of variation of the API concentration should be not more than 5.0% at the 10 g sampling scale when sampled according to ISO 6497. A stepwise dilution is required; direct blending of concentrated Qingdai powder into a full-size mixer without a pre-blend step can produce localized color streaks and random sampling outlier results, particularly when the API is added to a moving mixer as one discrete charge. The carryover risk between batches is elevated by the intense blue color of indigo; even a 0.01% residue in a subsequent poultry ration can be visually detectable on feed pellets and trigger a customer complaint. For this reason, production lines running Qingdai premixes usually require a dedicated or washable mixer, validated cleaning with a colored powder recovery test, and physical separation from unmedicated feed lines. The premix is often extruded or pelleted at conditioning temperatures of 70°C to 85°C for 30 seconds to 120 seconds, but the thermal stability of the indigo and indirubin fractions under pelletizing conditions is not fully documented; published data for this specific veterinary API in pelleted feed is limited, so a stability-indicating assay should be performed on the final pelleted ration before a shelf life is assigned. In addition, residual solvent and elemental impurity levels must comply with VICH GL18 and the relevant regional feed safety regulations when the API is supplied as a non-sterile powder for in-feed use.
During high-shear wet granulation of Qingdai oral granules, water activity rather than added water volume controls the endpoint because the porous botanical matrix absorbs binder solution unevenly and does not exhibit a sharp torque inflection. A granulation run with 10% w/w to 15% w/w purified water and 2.0% w/w to 4.0% w/w povidone K30 will produce a wet mass that passes a 2.0 mm screen and dries to granules with a friability below 2.0%. If the water activity of the dried granules exceeds 0.45, the residual moisture plasticizes the amorphous regions of the binder and causes granule hardness to rise during storage, while disintegration time may shift from 5 min to more than 15 min in 37°C water per USP <701>. Fluid-bed drying at an inlet air temperature of 60°C to 70°C and a product temperature not above 40°C is preferred over tray drying because tray drying can produce moisture gradients within the bulk and color migration toward the surface of the granules. Over-drying below 1.0% moisture increases the proportion of fines and can lead to segregation during packaging; a particle size distribution target of 0.5 mm to 1.6 mm with not more than 15% fines is commonly selected for oral administration by top dressing or drinking-water application. The dissolution behavior of these granules is evaluated by USP <711> with paddle speed 50 rpm in 900 mL of an aqueous medium, but because Qingdai powder contains water-insoluble indigo, the dissolution test may require a surfactant or a co-solvent to discriminate between batches; published data for this specific configuration is limited, so the test method must be developed on a product-specific basis. Granule packaging should be selected to maintain water activity below 0.45; aluminium foil strip packs or high-barrier polyethylene terephthalate/aluminium foil/polyethylene laminates are typically applied when the product is marketed for use in humid climates.
Aqueous oral drenches containing Qingdai powder become suspension-like unless a co-solvent or wetting agent is incorporated at a defined ratio. When a true solution is required, the formulator must first characterize the solubility of the indigo and indirubin fractions in propylene glycol, glycerol, ethanol and polysorbate 80; published data for this specific veterinary API in complex oral vehicles is limited, and solubility in water is known to be low. A typical non-sterile oral drench for cattle or sheep may contain 10% v/v to 20% v/v propylene glycol as a wetting and dispersing aid, 0.1% w/w sodium benzoate or potassium sorbate as preservative, and sufficient citric acid or sodium citrate to buffer the vehicle at pH 4.5 to 5.5. The pH range is narrow because alkaline conditions facilitate oxidation of phenolic constituents and can shift the color of the preparation from blue to brown, while overly acidic conditions below pH 4.0 can cause precipitation of some botanical components and reduce physical stability upon storage at 25°C and 60% RH. Sedimentation is measured by allowing a 100 mL graduated sample to stand undisturbed for 24 h; the sediment height should not exceed 5% of the total volume and must redisperse within 30 seconds of gentle shaking. The preservative efficacy test is performed according to Ph. Eur. 5.1.3 or the equivalent regional method, and the fill volume net content is checked against the tolerances in the relevant pharmacopoeial general chapter. For oral drench solutions, the API must be free of microbial contamination and meet the microbial limits for oral veterinary preparations; if the product is derived from a botanical source, the total aerobic microbial count and total yeast and mold count are controlled by Ph. Eur. 5.1.4 or USP <61> and <62>, with absence of Salmonella and Escherichia coli demonstrated by the specified enrichment method. Packaging in amber high-density polyethylene bottles with child-resistant closures is used to protect the indigo chromophore from photodegradation; the label should state the resuspendability instruction and storage temperature limit, typically not more than 25°C.
Powdered oral formulations for pre-ruminant calves and lambs require a different blending approach than feed premixes because the dose is administered directly rather than diluted into a complete ration. The API is dispersed in a water-soluble or water-dispersible carrier such as lactose monohydrate, glucose or maltodextrin, with 1.0% w/w to 2.0% w/w colloidal silicon dioxide to reduce cohesion and improve flow from the measuring scoop. The blend is passed through a 0.5 mm screen to break agglomerates, then mixed in a V-blender or bin blender for 15 min to 30 min at 60% to 70% of nominal volume; the target relative standard deviation of API content is not more than 5.0% across 10 samples taken from different locations. Because the powder is intended for direct oral administration, the particle size must be small enough to avoid palatability rejection but not so fine as to form a non-wettable dust when the farmer mixes it with milk replacer or water. A wetting agent such as polysorbate 80 at 0.05% w/w can be added to improve dispersibility in milk replacer, but levels above 0.2% w/w may generate foaming that complicates bottle feeding. The powder should be dried to loss on drying below 3.0% to control microbial growth and to maintain the free-flowing character during storage in high-density polyethylene jars with heat-sealed foil liners. Routine quality control includes sieve analysis, loss on drying, bulk density, tap density and content uniformity per USP <905> when the product is presented as a unit-dose powder; when the product is a multi-dose powder, the sampling plan is based on ISO 6497 rather than unit-dose acceptance criteria. Published data for Qingdai powder in oral powders for pre-ruminants is limited, so the blending validation should include a worst-case study using the lowest API concentration and a carryover study using the same equipment with a visible colored powder to demonstrate cleaning effectiveness.
Competitive Qingdai Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Qingdai Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions is a standardized botanical active pharmaceutical ingredient prepared from the dried aerial parts of Baphicacanthus cusia (Nees) Bremek., Polygonum tinctorium Aiton, or Isatis indigotica Fortune ex Lindl. The material is supplied as a blue to dark blue powder and is graded for particle size rather than sold as a single undifferentiated milled powder. Model designations QD-V-100, QD-V-200 and QD-V-400 correspond to nominal sieve cut points of 150 µm, 75 µm and 38 µm, respectively. QD-V-100 is intended for medicated premix and low-shear blending, QD-V-200 for oral powders, capsules and granules, and QD-V-400 for tablet compression and suspension-based liquid preparations after further processing. In each grade, release is controlled by marker content for indigo and indirubin, as well as by loss on drying, total ash, acid-insoluble ash, heavy metals and microbial limits.
Release control for the veterinary grade differs from unprocessed decoction-piece powder because the API must satisfy a defined particle size distribution before use in automated veterinary pharmaceutical equipment. The material is produced by drying, comminution, mechanical classification and, for the micronized grade, fluid-energy milling. The process is performed under veterinary GMP, with cleaning validation to control cross-contact with other botanical APIs. This grade is not interchangeable with dye-grade Qingdai powder or with the crude herb slice used in traditional decoction.
Release testing is organized around compendial methods for botanical drugs and veterinary premix safety. Table 1 lists representative release criteria for the QD-V-200 grade. The criteria are not universal; they must be adjusted to the target animal species, route of administration and regional submission. Values for heavy metals use microwave-assisted digestion and inductively coupled plasma mass spectrometry per USP <233>. The assay method uses reversed-phase high-performance liquid chromatography with a C18 column, phosphate buffer–methanol gradient elution, and detection wavelengths selected for indigo and indirubin.
| Attribute | Reference Method | Acceptance Criterion |
|---|---|---|
| Appearance | Visual inspection | Blue to dark blue powder; no visible foreign particles |
| Loss on drying | USP <731>, 105 °C | ≤ 12.0% |
| Total ash | USP <561>, 600 °C | ≤ 15.0% |
| Acid-insoluble ash | USP <561>, hydrochloric acid digestion | ≤ 5.0% |
| Indigo assay | HPLC, external standard | ≥ 2.0% on dried basis |
| Indirubin assay | HPLC, external standard | ≥ 0.13% on dried basis |
| Particle size | USP <786> | NLT 95% passes 75 µm; NMT 5% retained on 150 µm |
| Bulk density | USP <616>, Method I | 0.35–0.55 g/cm³ |
| Total aerobic microbial count | USP <61> | ≤ 104 CFU/g |
| Total yeast and mould count | USP <61> | ≤ 102 CFU/g |
| Escherichia coli | USP <62> | Absent in 10 g |
| Salmonella | USP <62> | Absent in 10 g |
| Lead | ICP-MS, USP <233> | ≤ 5 mg/kg |
| Cadmium | ICP-MS, USP <233> | ≤ 0.3 mg/kg |
| Arsenic | ICP-MS, USP <233> | ≤ 2 mg/kg |
| Mercury | ICP-MS, USP <233> | ≤ 0.2 mg/kg |
Bulk density values are target ranges, not universal constants, because particle morphology shifts with seasonal moisture uptake. If the powder is stored above 60% relative humidity without desiccant, loss-on-drying values can rise within 72 h and alter flow function coefficients measured by a ring shear test. The moisture uptake is reversible by tray drying at 40 °C for 6 h, but each site should qualify the drying endpoint against the release specification.
Across veterinary manufacturing lines, segregation of active powder from granular carriers is governed by the ratio of API D90 to carrier D50, bulk density difference and electrostatic charge accumulation. In a 2,000 L double-ribbon blender operating at 10 rpm with a 0.7 fill fraction, QD-V-200 is pre-blended with lactose monohydrate 200 M at 1:5 w/w before addition to a premix carrier. Electrostatic adhesion to stainless steel walls during dry blending is reduced by maintaining 40–50% relative humidity and grounding the blender body. The pre-blend step is required because the botanical powder has a higher specific surface area than typical inorganic mineral carriers and can stratify when dumped directly into a top-loaded blender.
Particle size distribution is measured by analytical sieving per USP <786> and by laser diffraction per ISO 13320-1:2020. The QD-V-200 grade should have no more than 5% retained on 150 µm and no less than 95% passing 75 µm; the QD-V-400 grade should have no less than 95% passing 38 µm. If a ribbon blender has a discharge cone angle greater than 45°, bridging can occur at the outlet because the powder has a bulk density below 0.60 g/cm³ and a leaf-particle morphology with high aspect ratio. Validation through stratified sampling at 10 locations after 5 min, 10 min and 15 min is required to establish a product-specific mixing curve. Published data for all possible carrier combinations is limited.
For direct compression tablets, QD-V-400 with a D90 near 38 µm is blended with microcrystalline cellulose PH-102, croscarmellose sodium and magnesium stearate. The low bulk density and high specific surface area of the micronized botanical powder reduce die filling uniformity at rotary press speeds above 60 rpm on a 16-station machine. Tablet breaking force is measured by USP <1217>, and content uniformity is assessed by USP <905>. Blends with relative standard deviation above 6.0% before compression are rejected. On single-station compression, ejection force increases when magnesium stearate concentration falls below 0.50% w/w, because the botanical API increases wall friction. A dry granulation step is used when the blend bulk density is below 0.40 g/cm³ to improve flow and reduce segregation under high-speed compression.
Pre-drying the API at 40 °C for 6 h before direct compression is required when storage relative humidity has exceeded 60%. Residual moisture above 12.0% can cause sticking to upper punches and variable tablet weight. The use of colloidal silicon dioxide at 0.25–0.50% w/w has been necessary in some production runs to coat the leaf-derived particles and improve die filling, but the silica concentration must be controlled because excess silica reduces tablet hardness and increases erosion.
The primary degradation pathways for Indigo naturalis markers in veterinary premixes are oxidative bleaching and alkaline hydrolysis. The API should not be dry-mixed with strongly alkaline carriers such as calcium carbonate or magnesium oxide at levels above 5 g/kg of finished feed unless the premix is coated. Prolonged exposure to light in clear packaging reduces the blue color intensity; light protection by amber PVC/PVDC or HDPE with carbon black is required for stock solutions. Above 60% relative humidity, pre-drying at 40 °C for 6 h is required before weighing. Avoid combining the powder with chlorine-based sanitizers or strong oxidizers because indigo is irreversibly oxidized to isatin derivatives. The operational boundary for pH in aqueous mixtures is 6.0–8.0; below pH 4.0 or above pH 9.0, marker recovery should be monitored. Published data for marker recovery in all possible feed matrices is limited.
Stability protocols should follow VICH GL3 and VICH GL4 for veterinary medicinal products. A target shelf life is not assigned solely from raw API data; however, primary stability batches are typically stored at 25 °C/60% RH and 40 °C/75% RH in sealed HDPE drums with desiccant for up to 24 months. The formulator should generate product-specific data before assigning a retest date or finished-product shelf life.
Injectable preparations based on Qingdai Powder Veterinary Grade API require marker-specific rational development because indigo and indirubin are practically insoluble in water. Direct use of the powder in an aqueous vehicle results in particulate matter counts above USP <788> limits for large-volume injections. The API must be processed into a sterile extract, liposomal dispersion or non-aqueous co-solvent system, with final filtration through a 0.22 µm sterilizing-grade membrane. Endotoxin control follows USP <85>, with a final product limit of less than 0.5 EU/mg for parenteral administration to small animals. For lyophilized powders, the excipient matrix includes mannitol and sodium citrate; reconstitution time should not exceed 5 min at 25 °C to avoid visible aggregate formation. If a solution is required at room temperature, pH adjustment alone is generally insufficient; solubilisation with cyclodextrin derivatives or surfactant systems must be evaluated under VICH GL4.
Particulate matter in injectable formulations is controlled by USP <787> for small-volume injections and USP <788> for large-volume injections. Terminal sterilisation by autoclaving at 121 °C for 15 min is not always feasible because the marker compounds may degrade; filtration is preferred for solutions or lipid nanocarriers after confirming filter compatibility. The formulator should verify that the selected sterilising-grade filter does not adsorb indigo or indirubin from the vehicle; nylon and PTFE filters have different adsorption profiles, and a filter compatibility study is required before scale-up.
Whole Qingdai Powder Veterinary Grade API retains the botanical matrix, whereas refined indigo extract is obtained by selective solvent extraction and precipitation, yielding a product with higher indigo content but reduced or absent co-occurring phytoconstituents. Synthetic indigo is an industrial dye product and is not normally accepted as a veterinary active pharmaceutical ingredient because its impurity profile and crystal habit differ from the botanical drug substance. Table 2 summarizes key differences relevant to formulation and regulatory filing.
| Parameter | Whole Qingdai Powder Veterinary Grade API | Refined Indigo Extract | Synthetic Indigo |
|---|---|---|---|
| Marker assay | Indigo ≥ 2.0%; indirubin ≥ 0.13% | Indigo typically 10–95% depending on supplier; indirubin variable | Purity ≥ 95% as industrial dye |
| Co-actives | Botanical matrix retained; co-occurring alkaloids and polysaccharides present | Limited botanical co-actives; higher marker load | None; may contain aniline and N-methylaniline residues |
| Aqueous solubility | Practically insoluble; less than 1 mg/mL at 25 °C | Practically insoluble in water; soluble in selected organic solvents | Insoluble in water; not processed for pharmaceutical particle sizing |
| Particle engineering | Mechanical sieving or fluid-energy milling; grades 150 µm, 75 µm, 38 µm | Crystallisation, spray drying or precipitation; particle size supplier-dependent | Dye paste or milled powder; not designed for inhalation or injection |
| Primary dosage forms | Premix, oral powder, granule, capsule, tablet; injectable after extraction or processing | High-potency solid dose, research injectable, topical | Not recommended as a veterinary drug ingredient |
| Regulatory status | Compendial botanical API under veterinary GMP | Requires full drug master file; not automatically covered by the same monograph | Not a veterinary API under current pharmacopoeias; requires extensive impurity qualification |
| Process risk | Hygroscopic, electrostatic, dose variability without pre-blend | Crystalline bridging, low bulk density, assay variability | Dye-grade residues, non-pharmaceutical particle size, no microbial control |